<?xml version="1.0" encoding="UTF-8"?>
<p>In the context of Ebola virus, a meta-analysis of clinical studies was conducted during the West Africa Ebola virus disease outbreak, gathering a pool of 1147 individuals. This analysis acknowledged that studies were considerably limited by the lack of randomization.
 <sup>
  <xref rid="R17" ref-type="bibr">17</xref>
 </sup> A large, non-randomized study of 84 patients pointed to a non-significant 7% decrease in death risk following transfusion of up to 500â€ŠmL of convalescent plasma, albeit with unknown levels of neutralizing antibodies.
 <sup>
  <xref rid="R18" ref-type="bibr">18</xref>
 </sup> Nevertheless, transfusion of convalescent plasma or whole blood collected from patients that recovered from Ebola virus has been recommended by the World Health Organization as an empirical treatment for the Ebola outbreaks, with provision of guidance also about the selection of donors, screening, and handling of blood and plasma units.
 <sup>
  <xref rid="R19" ref-type="bibr">19</xref>
 </sup>
</p>
